Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    " July 17, 2013":" August 16, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Safety and Immunological Response of a Boosting Dose of MVA-B in Healthy Volunteers After 4 Years of Receiving MVA-B
Condition: HIV Infections
Intervention: Biological: Experimental
2 Unknown  IL-23/IL-12 Imbalance and T Lymphocyte Polarization in HIV Infection
Condition: HIV Reservoirs
Intervention: Other: Blood sample and recto-colic biopsies
3 Recruiting Study of Immune Responses Induced by a HIV Vaccine
Condition: HIV Infections
Interventions: Biological: AIDSVAX B/E;   Biological: AIDSVAX B/E Placebo
4 Active, not recruiting Study of Boosting Strategies After Vaccination With ALVAC-HIV and AIDSVAX® B/E
Condition: HIV Infections
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: ALVAC-HIV Placebo;   Biological: AIDSVAX B/E Placebo
5 Withdrawn Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA Vaccine;   Biological: MVA/HIV62B Vaccine;   Biological: Placebo for DNA GEO-D03;   Biological: Placebo for MVA/HIV62B Vaccine
6 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
7 Unknown  Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire
Condition: HIV Infection
Intervention:
8 Active, not recruiting Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric Participants
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: EVG;   Drug: Background regimen
9 Recruiting Maternal HIV: Trial to Assist Disclosure to Children
Condition: HIV
Intervention: Behavioral: TRACK Intervention
10 Completed X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study
Condition: Hiv Infection
Intervention: Biological: A peripheral blood sample
11 Completed Juvenile Detention to Community Life
Conditions: Substance Use;   Delinquency;   Risk for HIV Infection
Interventions: Behavioral: Multidimensional Family Therapy Cross-Systems;   Behavioral: Enhanced Services as Usual
12 Unknown  The ACCLAIM Project
Condition: HIV
Interventions: Behavioral: Community leader engagement;   Behavioral: Community days;   Behavioral: Community Peer Groups
13 Enrolling by invitation Multi-component HIV Intervention Packages for Chinese Men Who Have Sex With Men —Test, Link and Care (TLC)
Condition: HIV/AIDS
Intervention: Behavioral: Enhancing HIV testing
14 Completed Mfangano Island Healthy Networks Impact Study
Condition: HIV
Intervention: Behavioral: Mfangano Health Net Microclinic Program
15 Completed Male Engagement in PMTCT Services
Condition: HIV
Interventions: Other: clinic based intervention;   Other: clinic and community based intervention
16 Completed Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
Condition: HIV/AIDS
Interventions: Behavioral: Focus On Youth;   Behavioral: Health Education Control Condition
17 Active, not recruiting Treatment With Probiotics (Saccharomyces Boulardii) and Its Role in Bacterial Translocation and Immune Reconstitution in VIH Infection.
Condition: HIV -1 Infection
Interventions: Dietary Supplement: Probiotic.;   Dietary Supplement: Placebo
18 Recruiting HBV-HIV Coinfection Research Network
Conditions: Hepatitis B;   Human Immunodeficiency Virus
Intervention:
19 Active, not recruiting
Has Results
A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir/abacavir/lamivudine FDC;   Drug: Atazanavir;   Drug: Ritonavir;   Drug: Tenofovir/emtricitabine FDC
20 Unknown  Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C
Conditions: Hepatitis C, Chronic;   HIV
Interventions: Drug: Pegylated interferon alpha-2a;   Drug: Ribavirin;   Drug: Boceprevir

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.